Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
During a presentation at the EURETINA 2021 Virtual Congress, José-Alain Sahel, MD, explains that optogenetics involves the use of artificial photoreceptors from specific retinal cells to restore vision by transferring a gene that encodes for a light-sensitive protein that causes neuronal cells to respond to light stimulation.
This conference titled, “The Top Ten Things I Wish I Knew Sooner,” is the brainchild of Lisa M. Nijm, MD, JD, who has had the foresight to help young ophthalmologists negotiate the choppy waters of a new practice.
Treating the disease can be a challenge, and at the EURETINA 2021 Virtual Congress, Chekitaan Singh, MD, discussed a case study detailing the care of a patient who had already lost vision in one eye from a similar issue.
Speaking during the EURETINA 2021 Virtual Congress, Marta Belmonte-Grau, MD, discussed the potential risk for posterior capsular rupture during cataract surgery.
Investigators find imaging method may be useful to monitor disease progression.
Development of new animal model enhances study of genetic mutations.
Study examines immunomodulatory as a potential long-term treatment option.
Scanning laser ophthalmoscopy offers improved view of posterior segment.
Approval may inspire increased vaccination effort.
Findings from the Archway trial showed that the PDS effect is long-lasting, consistent, and comparable to those seen with monthly injections.
Visual benefit is not seen during first 2 years of Protocol W study.
Dexamethasone implant, aflibercept offer a safe treatment option for diabetic macular edema.
Results may represent a retinal degenerative change.
The EURETINA 2021 Virtual Meeting is scheduled for September 9 to 12, 2021, and retina specialists eagerly await the showcase of cutting-edge scientific developments.
Investigators have found that 78% of neovascular AMD cases have been detected using the PHP home monitoring system.
A team of investigators found that the retina may offer signs of COVID-19 infection before symptoms present.
Trial shows treatment has acceptable safety profile, may improve visual function.
AAO develops task forces to evaluate academy, review outcomes in ophthalmology.
Physicians should hospitalize ON patients to prevent blindness, possible death.
Structural photoreceptor abnormalities and an area of central sparing found.
Deep learning predictions of the retinal nerve fiber layer thickness based solely on fundus photographs can be used to monitor the risk of future glaucomatous conversion in glaucoma suspects.
Clues to diagnosis from patient and family histories, examination techniques.
In a study, a single intravitreal injection of ADVM-022 had a 99% reduction in the mean annualized frequency of anti-VEGF injections.
Investigators corroborate the hypothesis that retinal ganglion cells with dendrites stratified in the off sublaminae could be damaged.
In endophthalmitis, the systemic anti-infective treatment specific to the infectious agent should always be used.
Amid pandemic, physicians and patients have embraced remote technology.
Measures of inflammation can predict treatment outcomes for patients
An updated PDS procedure reduces complications.
RGX-314 eyed by investigators as a therapeutic option for exudative AMD.
Preexisting neutralizing antibodies associated with the inflammatory changes.
